BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34894495)

  • 21. Quantitative Analysis of [
    Shi K; Bayer C; Astner ST; Gaertner FC; Vaupel P; Schwaiger M; Huang SC; Ziegler SI
    Mol Imaging Biol; 2017 Feb; 19(1):120-129. PubMed ID: 27379986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function.
    Lindblom E; Dasu A; Uhrdin J; Even A; van Elmpt W; Lambin P; Wersäll P; Toma-Dasu I
    Acta Oncol; 2017 Jun; 56(6):819-825. PubMed ID: 28464740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
    Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J
    Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.
    Mortensen LS; Johansen J; Kallehauge J; Primdahl H; Busk M; Lassen P; Alsner J; Sørensen BS; Toustrup K; Jakobsen S; Petersen J; Petersen H; Theil J; Nordsmark M; Overgaard J
    Radiother Oncol; 2012 Oct; 105(1):14-20. PubMed ID: 23083497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
    Wiedenmann N; Grosu AL; Büchert M; Rischke HC; Ruf J; Bielak L; Majerus L; Rühle A; Bamberg F; Baltas D; Hennig J; Mix M; Bock M; Nicolay NH
    Radiother Oncol; 2020 Sep; 150():128-135. PubMed ID: 32544609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
    Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA
    J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
    Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
    PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.
    Bruine de Bruin L; Bollineni VR; Wachters JE; Schuuring E; van Hemel BM; van der Wal JE; Slagter-Menkema L; de Bock GH; Steenbakkers RJ; Langendijk JA; Pruim J; van der Laan BF; Halmos GB
    Radiother Oncol; 2015 Oct; 117(1):106-12. PubMed ID: 26250803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
    Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
    Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
    Han K; Fyles A; Shek T; Croke J; Dhani N; D'Souza D; Lee TY; Chaudary N; Bruce J; Pintilie M; Cairns R; Vines D; Pakbaz S; Jaffray D; Metser U; Rouzbahman M; Milosevic M; Koritzinsky M
    Clin Cancer Res; 2022 Dec; 28(24):5263-5271. PubMed ID: 36037303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.
    Georg P; Andrzejewski P; Baltzer P; Daniel M; Wadsak W; Mitterhauser M; Sturdza A; Majercakova K; Karanikas G; Pötter R; Hacker M; Helbich T; Georg D; Pinker K
    Mol Imaging Biol; 2018 Feb; 20(1):160-169. PubMed ID: 28540524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.
    Doot RK; Scheuermann JS; Christian PE; Karp JS; Kinahan PE
    Med Phys; 2010 Nov; 37(11):6035-46. PubMed ID: 21158315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
    J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity.
    Busk M; Munk OL; Jakobsen SS; Horsman MR
    Acta Oncol; 2017 Nov; 56(11):1583-1590. PubMed ID: 28840765
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
    Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulating NEMA characteristics of the modular total-body J-PET scanner-an economic total-body PET from plastic scintillators.
    Moskal P; Kowalski P; Shopa RY; Raczyński L; Baran J; Chug N; Curceanu C; Czerwiński E; Dadgar M; Dulski K; Gajos A; Hiesmayr BC; Kacprzak K; Kapłon Ł; Kisielewska D; Klimaszewski K; Kopka P; Korcyl G; Krawczyk N; Krzemień W; Kubicz E; Niedźwiecki S; Parzych S; Raj J; Sharma S; Shivani S; Stępień E; Tayefi F; Wiślicki W
    Phys Med Biol; 2021 Sep; 66(17):. PubMed ID: 34289460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors.
    Adam LE; Karp JS; Daube-Witherspoon ME; Smith RJ
    J Nucl Med; 2001 Dec; 42(12):1821-30. PubMed ID: 11752080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.